Summary by Futu AI
China Biopharmaceuticals Limited issued a notice to the registered shareholders on 29 April 2024 announcing that it has published the 2023 Annual Report on the Company's website and the website of the United Stock Exchange of Hong Kong Limited, General Mandates to Issue and Repurchase Shares, Re-Election of Directors and Notice of Annual General Meeting, and Proxy Form. THE COMPANY ENCOURAGES SHAREHOLDERS TO READ THIS AND FUTURE CORPORATE NEWSLETTERS VIA THE WEBSITE VERSION AND TO PROVIDE THE OPTION FOR SHAREHOLDERS TO CHOOSE TO RECEIVE THEM IN PRINTED FORM. The Company also reminds shareholders to update a valid email address in order to receive future corporate communications and posting notifications via email. Shareholders may contact the Share Transfer Register Office during business hours if they have any questions.